Publications dans lesquelles il/elle collabore avec Sara Domínguez Rodríguez (37)

2024

  1. High mortality following early initiation of antiretroviral therapy in infants living with HIV from three African countries

    eClinicalMedicine, Vol. 73

  2. Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART

    Frontiers in Immunology, Vol. 15

  3. Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial

    Clinical Infectious Diseases, Vol. 78, Núm. 3, pp. 702-710

2023

  1. Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change

    Journal of Acquired Immune Deficiency Syndromes, Vol. 93, Núm. 1, pp. 42-46

  2. Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile

    Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674

  3. First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 11, pp. 581-585

  4. PACTA-Ped: programa de optimización de antimicrobianos en un hospital de tercer nivel en España

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 99, Núm. 5, pp. 312-320

  5. Testing the performance, adequacy, and applicability of an artificial intelligence model for pediatric pneumonia diagnosis

    Computer Methods and Programs in Biomedicine, Vol. 242

  6. The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission

    PLoS ONE, Vol. 18, Núm. 2 February

  7. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children

    Frontiers in Immunology, Vol. 13

  2. Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy

    Frontiers in immunology, Vol. 13, pp. 860418

  3. Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial

    Trials, Vol. 23, Núm. 1

  4. Factors associated with late presentation for HIV care in adolescents in Spain

    HIV Medicine, Vol. 23, Núm. 11, pp. 1195-1201

  5. Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS

    PloS one, Vol. 17, Núm. 10, pp. e0276116

  6. Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence

    BMC public health, Vol. 22, Núm. 1, pp. 1312

  7. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

    Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058

  8. Prevalence of psychological symptoms and associated risk factors in a Spanish sample of HIV-positive youth compared to uninfected peers

    Anales de Pediatria, Vol. 96, Núm. 3, pp. 203-212

  9. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  10. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263